CDK2 phosphorylation regulates the protein stability of KLF10 by interfering with binding of the E3 ligase SIAH1

Ching-Hui Lin1, Shu-Yu Lin2, Hsuen-Wen Chang3

  • 1National Institute of Cancer Research, National Health Research Institutes, Taipei, Taiwan.

Insights

Cyclin-dependent kinase 2 (CDK2) phosphorylation stabilizes the tumor suppressor KLF10 by preventing its degradation. This CDK2-dependent regulation impacts KLF10

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Transforming growth factor-beta 1 (TGF-β1) inhibits human carcinoma cell proliferation via cell cycle regulation.
  • KLF10, a known tumor suppressor, mimics TGF-β1's anti-proliferative and apoptotic effects on epithelial and tumor cells.
  • KLF10 protein levels are linked to cell cycle events, but its regulatory mechanisms remain unclear.

Purpose of the Study:

  • To elucidate the regulatory mechanism of KLF10 protein expression.
  • To identify the specific kinase responsible for KLF10 phosphorylation.
  • To understand how KLF10 phosphorylation affects its stability and function in cell cycle regulation.

Main Methods:

  • Mass spectrometry to identify phosphorylation sites.
  • Site-directed mutagenesis to confirm kinase activity.
  • In vitro kinase assays to assess CDK2 interaction and phosphorylation.
  • Depletion assays to evaluate the role of SIAH1 in KLF10 degradation.

Main Results:

  • KLF10 is phosphorylated by CDK2/cyclin E, with strong binding to CDK2.
  • CDK2 specifically phosphorylates KLF10 at Serine 206 (Ser206).
  • CDK2-mediated phosphorylation stabilizes KLF10 by reducing its interaction with the E3-ubiquitin ligase SIAH1, thereby inhibiting proteasomal degradation.

Conclusions:

  • CDK2-dependent phosphorylation is a key regulator of KLF10 protein stability.
  • This phosphorylation mechanism influences KLF10's role as a tumor suppressor.
  • Understanding this pathway offers insights into controlling cell proliferation in human carcinomas.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.6K